Connect with us

Hi, what are you looking for?

Investing

Strategic Co-Development Partnership with Lantheus for Aus

Radiopharm Theranostics (RAD:AU) has announced Strategic Co-Development Partnership with Lantheus for Aus

Download the PDF here.

This post appeared first on investingnews.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.







    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    California Gov. Gavin Newsom railed against President-Elect Trump’s proposal to impose 25% tariffs on goods from Mexico and Canada during a visit to the...

    Latest News

    Let’s face it, trust in most of our government institutions has utterly collapsed. Many people don’t have faith in the FDA, the DOD, HUD,...

    Stock

    The first trading week in December started on a positive note, with the S&P 500 ($SPX) and Nasdaq Composite ($COMPQ) notching new all-time highs,...

    Latest News

    President-elect Trump expressed public support for embattled defense secretary nominee Pete Hegseth Friday, and the nominee said he had a ‘substantive conversation’ with Sen....

    Disclaimer: Greenlightinvestings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Greenlightinvestings.com